1. Home
  2. ZURA vs BTBT Comparison

ZURA vs BTBT Comparison

Compare ZURA & BTBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Zura Bio Limited

ZURA

Zura Bio Limited

N/A

Current Price

$0.97

Market Cap

455.4M

Sector

Health Care

ML Signal

N/A

Logo Bit Digital Inc.

BTBT

Bit Digital Inc.

N/A

Current Price

$0.52

Market Cap

427.6M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
ZURA
BTBT
Founded
2022
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Finance: Consumer Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
455.4M
427.6M
IPO Year
2021
2017

Fundamental Metrics

Financial Performance
Metric
ZURA
BTBT
Price
$0.97
$0.52
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
7
5
Target Price
★ $8.00
$3.25
AVG Volume (30 Days)
6.7M
★ 22.7M
Earning Date
10-27-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
★ $113,560,320.00
Revenue This Year
N/A
$14.71
Revenue Next Year
N/A
$176.59
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ 5.10
52 Week Low
$0.92
$0.58
52 Week High
$7.25
$2.48

Technical Indicators

Market Signals
Indicator
ZURA
BTBT
Relative Strength Index (RSI) 24.64 27.19
Support Level $0.93 N/A
Resistance Level $5.97 $1.75
Average True Range (ATR) 0.23 0.08
MACD -0.15 0.00
Stochastic Oscillator 0.46 0.78

Price Performance

Historical Comparison
ZURA
BTBT

About ZURA Zura Bio Limited

Zura Bio Ltd is a clinical-stage biotechnology company developing novel medicines for patients with autoimmune and inflammatory diseases, including serious and debilitating conditions with unmet medical need. These diseases are often chronic, biologically complex, and difficult to treat, and many patients do not achieve durable disease control with existing therapies. The company has in-licensed three clinical-stage product candidates: Tibulizumab (ZB-106), a bispecific antibody targeting IL-17A and BAFF; Crebankitug (ZB-168), an IgG1 monoclonal antibody targeting IL-7R; and Torudokimab (ZB-880), an IgG4 monoclonal antibody targeting IL-33.

About BTBT Bit Digital Inc.

Bit Digital Inc is engaged in the Bitcoin mining business, Ethereum staking activities and specialized cloud-infrastructure services for artificial intelligence applications through its wholly owned subsidiaries. Its mining platform operates with the primary intent of accumulating bitcoin which may sell for fiat currency from time to time depending on market conditions. The Company has four reportable segments: digital asset mining, cloud services, colocation services, and ETH Staking. It generates majority of its revenue from digital asset mining.

Share on Social Networks: